結核性髄膜炎における抗結核治療の結果: 系統的レビューとメタ解析
Samin Afazel1, Mohammad J Nasiri1, Vishwanath Venketaraman2
1Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
New microbes and new infections
|September 2, 2025
まとめ
結核性髄膜炎 (TBM) は高い死亡率 (27. 7%) と神経障害,特にHIV陽性患者で発生します. 改善された診断と治療は TBM 管理の改善に不可欠です
科学分野:
- 神経科学
- 感染症
- 公衆衛生
背景:
- 結核性髄膜炎 (TBM) は,世界的に死亡と障害の大きな原因です.
- TBMの現在の治療結果は,改善すべき領域を特定するためにさらなる評価を必要としています.
研究 の 目的:
- TBM患者における抗結核薬の治療結果を体系的にレビューし,メタ分析する.
- TBMにおける死亡率と神経障害率の評価に重点を置く.
主な方法:
- PubMed/MEDLINE,EMBASE,およびCochrane CENTRALのデータベースに関する包括的な文献検索.
- 死亡率,神経障害,フォローアップへの損失を分析した2005人のTBM患者による10件の研究を含めた.
- 治療結果の総合分析のためのランダム効果モデル.
主要な成果:
- 全体的な死亡率は27. 7%で,HIV陽性患者 (40. 3%) とHIV陰性患者 (17. 1%) の比率は著しく高かった.
- フォローアップの損失は6. 6%でした. 死亡率は3ヶ月で18. 9%から6ヶ月で29. 1%に増加しました.
- 神経障害は,バーテル指数 (14. 1%) よりも,修正ランキンスケール (41. 7%) を用いてより頻繁に報告されました.
結論:
- TBMは高い死亡率と重大な神経障害と関連しており,特にHIVに併感染した個体ではそうである.
- 標準化された結果報告と新しい治療戦略は,TBM患者の結果を改善するために不可欠です.
- 将来の研究は,改善された診断ツールと最適化された治療プロトコルを優先して,TBMの負担を軽減する必要があります.
さらに関連する動画
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.9K
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.9K
関連する概念動画
01:28Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
01:26Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
01:29Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
01:31Pulmonary Tuberculosis III
439
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
439
01:28Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
01:28Pneumonia IV: Management
445
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
445